Related references
Note: Only part of the references are listed.Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy (vol 41, pg 1345, 2009)
Colin J. D. Ross et al.
NATURE GENETICS (2013)
Carboplatin-Associated Ototoxicity in Children With Retinoblastoma
Ibrahim Qaddoumi et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Hearing loss among survivors of childhood brain tumors treated with an irradiation-sparing approach
Etan Orgel et al.
PEDIATRIC BLOOD & CANCER (2012)
pROC: an open-source package for R and S plus to analyze and compare ROC curves
Xavier Robin et al.
BMC BIOINFORMATICS (2011)
Acute Mesenteric Infarction Associated with Atrial Fibrillation
Jia-Ming Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Practical Grading System for Evaluating Cisplatin Ototoxicity in Children
Kay W. Chang et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Challenges in management of patients with intracranial germ cell tumor and diabetes insipidus treated with cisplatin and/or ifosfamide based chemotherapy
Samina Afzal et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
S-Adenosyl-L-Methionine Increases Serum BUN and Creatinine in Cisplatin-treated Mice
Bernardo Ochoa et al.
ARCHIVES OF MEDICAL RESEARCH (2009)
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
Colin J. D. Ross et al.
NATURE GENETICS (2009)
Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma
Giorgio Perilongo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Ototoxicity in Children Treated for Osteosarcoma
Matthew J. Lewis et al.
PEDIATRIC BLOOD & CANCER (2009)
Application of principal component analysis to pharmacogenomic studies in Canada
H. Visscher et al.
PHARMACOGENOMICS JOURNAL (2009)
Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin
L. Riedemann et al.
PHARMACOGENOMICS JOURNAL (2008)
Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and-M1, a retrospective cross sectional study
Jan Oldenburg et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Pharmacogenomic testing to prevent aminoglycoside-induced hearing loss in cystic fibrosis patients: potential impact on clinical, patient, and economic outcomes
David L. Veenstra et al.
GENETICS IN MEDICINE (2007)
Replicating genotype-phenotype associations
Stephen J. Chanock et al.
NATURE (2007)
Ototoxicity after radiotherapy for head and neck tumors
Niranjan Bhandare et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Pharmacogenomics:: Catechol O-methyltransferase to thiopurine S-methyltransferase
Richard M. Weinshilboum
CELLULAR AND MOLECULAR NEUROBIOLOGY (2006)
The effect of treatment with vincristine on transient evoked and distortion product otoacoustic emissions
M. Riga et al.
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY (2006)
Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: A review
P Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Ototoxicity in children receiving platinum chemotherapy: Underestimating a commonly occurring toxicity that may influence academic and social development
KRG Knight et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Molecular mechanisms of reduced glutathione transport: role of the MRP/CFTR/ABCC and OATP/SLC21A families of membrane proteins
N Ballatori et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients
CC Pan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Identification and functional characterization of the natural variant MRP3-Arg1297 His of human multidrug resistance protein 3 (MRP3/ABCC3)
YMA Lee et al.
PHARMACOGENETICS (2004)
Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose
Y Li et al.
EUROPEAN JOURNAL OF CANCER (2004)
Platinum compound-related ototoxicity in children - Long-term follow-up reveals continuous worsening of hearing loss
P Bertolini et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2004)
Replication validity of genetic association studies
JPA Ioannidis et al.
NATURE GENETICS (2001)
Association between expression of the MRP3 gene and exposure to platinum drugs in lung cancer
T Oguri et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Up-regulation of transporters of the MRP family by drugs and toxins
D Schrenk et al.
TOXICOLOGY LETTERS (2001)
Bilateral transient hearing loss associated with vincristine therapy: Case report
I Aydogdu et al.
JOURNAL OF CHEMOTHERAPY (2000)
Cisplatin-induced hearing loss: influence of the mode of drug administration in the guinea pig
A Ekborn et al.
HEARING RESEARCH (2000)
Share Paper
